Commercially different variants of ethylene‐vinyl acetate (EVA) encapsulants are available in the photovoltaic (PV) market. Photobleaching and discoloration are the two most commonly observed phenomena, and their initiation may be different for different encapsulants. To investigate the EVA encapsulant photobleaching and discoloration, solar cell laminates having different EVA films (UV‐transparent [T], UV‐cut [C], and combination of the two [TC]) were tested in Xenon test chamber. High temperatures are created in the laminates during the aging tests by using a thick insulation layer behind the backsheet. The UV fluorescence images and grayscale profile show clear signs of photobleaching and discoloration. It is found that the oxygen diffusion coefficient of the T sample is four and nine times slower than the TC and C samples, respectively, in the photobleached region. Fluorescence imaging and spectra and Raman spectra were taken before and after the accelerated test and indicate that discoloration causing fluorophores generation is higher after the photobleached region for transparent and combined EVAs, whereas higher at the center for UV‐cut EVA laminates. A colorimeter was used to measure the Yellowness Index of the samples before and after the accelerated aging test. This work will help in the early detection of photobleaching and discoloration of any encapsulant used in the PV modules. This method will also help to study the behavior of encapsulants in different climatic conditions like hot, cold, dry, humid, and their combinations by simulating the same in an accelerated weathering chamber by using the different insulation thickness.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.